Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
72.48
-0.07 (-0.10%)
Mar 31, 2025, 10:13 AM EDT - Market open
Globus Medical Market Cap
Globus Medical has a market cap or net worth of $9.97 billion as of March 31, 2025. Its market cap has increased by 33.05% in one year.
Market Cap
9.97B
Enterprise Value
9.56B
1-Year Change
33.05%
Ranking
Category
Stock Price
$72.48
Market Cap Chart
Since August 3, 2012, Globus Medical's market cap has increased from $1.22B to $9.97B, an increase of 717.00%. That is a compound annual growth rate of 18.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 9.98B | -11.40% |
| Dec 31, 2024 | 11.26B | 53.38% |
| Dec 29, 2023 | 7.34B | -0.98% |
| Dec 30, 2022 | 7.42B | 1.22% |
| Dec 31, 2021 | 7.33B | 13.84% |
| Dec 31, 2020 | 6.44B | 9.95% |
| Dec 31, 2019 | 5.85B | 37.32% |
| Dec 31, 2018 | 4.26B | 7.60% |
| Dec 29, 2017 | 3.96B | 66.61% |
| Dec 30, 2016 | 2.38B | -10.27% |
| Dec 31, 2015 | 2.65B | 17.98% |
| Dec 31, 2014 | 2.25B | 19.34% |
| Dec 31, 2013 | 1.88B | 96.83% |
| Dec 31, 2012 | 956.00M | -21.65% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |